On March 28, 2025, the Second National Conference on Genomic Informatics was grandly held in Shenzhen. As a leading domestic gene sequencing technology enterprise, Polyseq Biotechnology attended this grand event with its independently developed nanopore sequencer and supporting products. And received coverage from the Shenzhen News program on Shenzhen TV.
Shenzhen TV reported on the exhibition of Polyseq Biotechnology at the conference, which not only reflects the technological breakthroughs of Polyseq Biotechnology's products, but also demonstrates great potential in practical applications, providing new solutions for genomics research and clinical applications.
This exhibition not only showcases the latest achievements of Polyseq Biotechnology in nanopore sequencing technology, but also provides new opportunities for multi-faceted cooperation and development in the field of genomics. Polyseq Biotechnology will continue to strive for innovation and application of nanopore sequencing technology, contributing to the development of genomics research and precision medicine.
About Translation Biology
Beijing Polyseq Biotechnology Co., Ltd. was established in November 2021, focusing on the research and commercialization of biological nanopore gene sequencing systems. Based on the principle of nanopore gene sequencing, the company constructs a sequencing chemistry system with independent intellectual property rights, using a newly independently analyzed biological nanopore atomic horizontal structure as the foundation, combined with nucleic acid chemistry, protein engineering, etc; Build a high-level sequencing platform using integrated circuit chips, software engineering, and deep learning algorithms; Developing high-precision, high-throughput, long read, low-cost nanopore sequencers and supporting reagents and consumables, enabling gene sequencing technology to enter medical institutions at all levels, benefiting the public, safeguarding the lives and health of the people, and meeting the needs of precision medicine in the era of big data.
